These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1259932)

  • 1. Chemotaxis for human monocytes by fibrinogen-derived peptides.
    Richardson DL; Pepper DS; Kay AB
    Br J Haematol; 1976 Apr; 32(4):507-13. PubMed ID: 1259932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
    Senior RM; Skogen WF; Griffin GL; Wilner GD
    J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
    Gurrieri MA
    Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological properties of fibrinogen degradation products by thrombin].
    Buczko W
    Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endogenous peptides--physiological regulators of coagulative conversion of fibrinogen].
    Byshevskiĭ ASh; Chiriat'ev EA; Leonova OP
    Gematol Transfuziol; 1991 Apr; 36(4):28-31. PubMed ID: 2065963
    [No Abstract]   [Full Text] [Related]  

  • 10. The proteolytic action of Arvin on human fibrinogen.
    Ewart MR; Hatton MW; Basford JM; Dodgson KS
    Biochem J; 1970 Jul; 118(4):603-9. PubMed ID: 5529716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels.
    Kodama M; Naito M; Nomura H; Iguchi A; Thompson WD; Stirk CM; Smith EB
    Life Sci; 2002 Jul; 71(10):1139-48. PubMed ID: 12095535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
    Hanna LS; Scheraga HA; Francis CW; Marder VJ
    Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain.
    Gross TJ; Leavell KJ; Peterson MW
    Thromb Haemost; 1997 May; 77(5):894-900. PubMed ID: 9184399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation.
    Wojtecka-Lukasik E; Maśliński S
    J Physiol Pharmacol; 1992 Jun; 43(2):173-81. PubMed ID: 1382726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.